Quick Answer
CHINA PHARMA HOLDINGS, INC. reported Total Revenue of $4.53 million for the year ending 2024.
- CHINA PHARMA HOLDINGS, INC. showed a decrease of -35.4% in Total Revenue from 2023 to 2024.
- This data is from CHINA PHARMA HOLDINGS, INC.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
- XBRL data for this metric is available from 2010 to 2024 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2010: $18.68 million | Q1 2011: $18.12 million | Q2 2011: $19.60 million | Q3 2011: $20.99 million | Q1 2012: $16.09 million | Q2 2012: $14.60 million | Q3 2012: $12.18 million | Q1 2013: $8.25 million | Q2 2013: $8.03 million | Q3 2013: $8.12 million | Q1 2014: $7.11 million | Q2 2014: $6.13 million | Q3 2014: $5.57 million | Q1 2015: $5.69 million | Q2 2015: $5.67 million | Q3 2015: $4.48 million | Q1 2016: $3.64 million | Q2 2016: $3.54 million | Q3 2016: $3.13 million | Q1 2017: $3.29 million | Q2 2017: $2.92 million | Q3 2017: $3.16 million | Q1 2018: $3.62 million | Q2 2018: $3.17 million | Q3 2018: $2.30 million | Q1 2019: $2.93 million | Q2 2019: $2.57 million | Q3 2019: $2.38 million | Q1 2020: $1.76 million | Q2 2020: $3.77 million | Q3 2020: $2.40 million | Q1 2021: $2.36 million | Q2 2021: $2.42 million | Q3 2021: $1.98 million | Q1 2022: $1.60 million | Q2 2022: $1.61 million | Q3 2022: $1.97 million | Q1 2023: $1.96 million | Q2 2023: $1.10 million | Q3 2023: $1.80 million | Q1 2024: $1.37 million | Q2 2024: $924.9 thousand | Q3 2024: $1.10 million | Q1 2025: $1.14 million | Q2 2025: $1.03 million | Q3 2025: $756.2 thousand.
- Over the full 15 years of available data (2010 to 2024), CHINA PHARMA HOLDINGS, INC.'s Total Revenue has declined by 93.9%.
- Historical annual values: Fiscal year 2024: $4.53 million | Fiscal year 2023: $7.01 million | Fiscal year 2022: $8.10 million | Fiscal year 2021: $9.64 million | Fiscal year 2020: $10.87 million | Fiscal year 2019: $10.92 million | Fiscal year 2018: $12.33 million | Fiscal year 2017: $13.21 million | Fiscal year 2016: $15.57 million | Fiscal year 2015: $20.35 million | Fiscal year 2014: $22.13 million | Fiscal year 2013: $32.81 million | Fiscal year 2012: $54.51 million | Fiscal year 2011: $81.17 million | Fiscal year 2010: $74.39 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: